Semaglutide for weight management is typically administered as a once-weekly subcutaneous injection, given in the abdomen, thigh, or upper arm
The question of whether GLP-1 medications cause tiredness applies across the class, not just to semaglutide
8 In the 2015 Canada Community Health survey, 60% of adult Canadians had a BMI greater than 25 kg/m 2 , with 43% of those being greater than 30 kg/m 2
Alcuni studi hanno evidenziato possibili effetti neuroprotettivi anche nei pazienti con malattia di Parkinson
Is GLP-1 medication a lifelong commitment
Neither compound has published the kind of long-term hard-outcome data (cardiovascular events, mortality) that ultimately defines a metabolic drugs value, because both are too early in development for that